Global Recombinant DNA Technology Market Size To Worth USD 1227.3 Billion by 2033 | CAGR of 5.25%
Category: HealthcareGlobal Recombinant DNA Technology Market Size To Worth USD 1227.3 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Recombinant DNA Technology Market Size is to Grow from USD 735.52 Billion in 2023 to USD 1227.3 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.25% during the projected period.
Get more details on this report -
Browse key industry insights spread across 250 pages with 121 Market data tables and figures & charts from the report on the "Global Recombinant DNA Technology Market Size, Share, and COVID-19 Impact Analysis, By Product (Medical Products and Non- medical Products), By Component (Expression System and Cloning Vector), By Application (Food & Agriculture, Health & Disease, Environment, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/recombinant-dna-technology-market
Recombinant DNA Technology (RDT) is the term for the technology that improves health conditions through the development of new vaccines and medications. RDT has revolutionized biological research and is now a vital tool for enhancing the qualities of living organisms. The wide range of industries, including industry, agriculture, and medicine, that this technology is applied to is what is fueling its expansion. The technology's ability to produce vital proteins needed for maintaining nutrition and preventing health issues has also contributed to its rising demand. The growing application of RDT in agriculture has enabled higher-yielding crops, disease-resistant cultivars, and higher nutritional content. Recombinant DNA-based product demand is expected to continue rising due to the need for long-term solutions to both address environmental issues and the world's growing food demand. A primary reason for this is the increasing demand for efficient treatments for various ailments, which has led to the development of vaccines and therapies based on recombinant DNA. However, the market for recombinant DNA technology is expected to grow slowly due to uncertainty surrounding gene modifications and ethical issues.
Medical products dominate the market with the highest market share of the global recombinant DNA technology market during the projected period.
Based on the product, the global recombinant DNA technology market is divided into medical products, and non- medical products. Among these, the medical products segment dominates the market with the highest market share of the recombinant DNA technology market during the projected period. Technology has transformed medicine and significantly altered how patients are treated. It has improved the ability to treat diseases by enabling the replacement of unhealthy or faulty genes with healthy ones.
The cloning vector segment is anticipated to grow at the fastest pace during the projected timeframe.
Based on the component, the global recombinant DNA technology market is categorized into expression system, and cloning vector. Among these, the cloning vector segment is anticipated to grow at the fastest pace during the projected timeframe. Versatile cloning vectors such as plasmids, viruses, and artificial chromosomes facilitate the production of valuable products, therapeutic proteins, and genetically modified organisms by introducing, amplifying, and expressing target genes.
The health & disease segment is anticipated to grow at the fastest pace during the projected timeframe.
Based on the application, the global recombinant DNA technology market is categorized into food & agriculture, health & disease, environment, and others. Among these, the health & disease segment is anticipated to grow at the fastest pace during the projected timeframe. The ability of the pharmaceutical industry to develop new treatments and improve existing ones has caused a revolution. rDNA technology enables more precise targeting of various diseases through gene therapies, vaccines, and recombinant proteins.
North America is expected to hold the largest share of the global recombinant DNA technology market over the forecast period.
Get more details on this report -
North America is expected to hold the largest share of the global recombinant DNA technology market over the forecast period. The public and private sector's push for biotechnology research is solidifying North America's leadership in recombinant DNA technology.
Europe is predicted to grow at the fastest pace in the global recombinant DNA technology market during the projected period. The presence of strong regulatory bodies entrusted with resolving ethical and scientific conundrums related to technology use has fostered regional progress.
Major vendors in the global recombinant DNA technology market are GenScript, Eli Lilly and Company, Pfizer Inc., Sanofi, New England Biolabs, GlaxoSmithKline plc, Thermo Fisher Scientific Inc., Biogen Inc., Merck & Co., Inc., Amgen Inc., Monsanto Company, F. Hoffmann-La Roche Ltd, Novartis AG, Profacgen, Novo Nordisk A/S, and Others.
Recent Developments
- In March 2022, VBI Vaccines Inc. released PreHevbrio (Recombinant Hepatitis B Vaccine) in the US to protect adults 18 years of age and older against viral infection caused by any known subtype of the hepatitis B virus (HBV).
Key Target Audience
- MarketPlayers
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global recombinant DNA technology market based on the below-mentioned segments:
Global Recombinant DNA Technology Market, By Product
- Medical Products
- Non-medical Products
Global Recombinant DNA Technology Market, By Component
- Expression System
- Cloning Vector
Global Recombinant DNA Technology Market, By Application
- Food & Agriculture
- Health & Disease
- Environment
- Others
Global Recombinant DNA Technology Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?